Leveljump Healthcare (JUMP) has received TSXV approval and closed its acquisition of a 14.6 per cent equity interest in Real Time Medical Inc.
It was in exchange for 2,494,576 units of Leveljump.
Each unit will be issued at a price of $0.66 per unit with each unit being comprised of three Leveljump common shares at a deemed price of $0.22 per share and one share purchase warrant of Leveljump.
Each warrant entitles the holder to acquire one additional common share of Leveljump at a price of $0.35 per common share by December 31, 2023.
The equity interest in Real Time was acquired through a mini-tender offer to the shareholders dated November 1, 2021, where Leveljump offered to acquire up to 19.9 per cent of Real Time in exchange for the units.
The holders of the Real Time shares who have tendered are all accredited investors.
Real Time Medical founders include three Canadian radiologists and a former GE PACS executive.
Its vision is to grow and operate a nationwide radiology collaboration service for Canadian radiologists, with world-class, patented diagnostic workload balancing, workflow orchestration, peer learning and diagnostic operations software.
Leveljump is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology.
Its subsidiary, CTS, provides off-site radiology readings for hospital emergency rooms and is a leader in the teleradiology space in Ontario.
Leveljump Healthcare Corp. (JUMP) is unchanged trading at $0.15 per share as of 1:12 p.m. EST.